Robert Anton Crotty, DPM | |
120 N Perkins Rd, Ste A, Stillwater, OK 74075 | |
(405) 743-3668 | |
(405) 743-1718 |
Full Name | Robert Anton Crotty |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 120 N Perkins Rd, Stillwater, Oklahoma |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1033210851 | NPI | - | NPPES |
480179134 | Other | OK | RAILROAD MEDICARE |
731313428001 | Other | OK | BLUE CROSS BLUE SHIELD |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
213E00000X | Podiatrist | 167 (Oklahoma) | Primary |
Mailing Address | Practice Location Address |
---|---|
Robert Anton Crotty, DPM 120 N Perkins Rd, Ste A, Stillwater, OK 74075-5524 Ph: (405) 743-3668 | Robert Anton Crotty, DPM 120 N Perkins Rd, Ste A, Stillwater, OK 74075 Ph: (405) 743-3668 |
News Archive
Is the US health system comprehensively meeting the needs of returning veterans? With the recent attention to mental illness in returning soldiers, and post traumatic stress disorder (PTSD) in particular, little research has focused on the medical care needs of those returning from Operation Enduring Freedom/Operation Iraqi Freedom, according to Dr. Susan Frayne, from the VA Palo Alto Health Care System and Stanford University, and colleagues.
Turning a vital component of cancer cells from bodyguard to assassin could form the basis of new cancer treatments, according to a report published this week.
In an advance that could help ease health and environmental concerns about the emerging nanotechnology industry, scientists are reporting development of technology for changing the behavior of nanoparticles in municipal sewage treatment plants - their main gateway into the environment.
Scientists from Brigham and Women's Hospital and Dana-Farber Cancer Institute and their colleagues have found a genetic marker that predicts which aggressive "triple negative" breast cancers and certain ovarian cancers will likely respond to platinum-based chemotherapies.
Pan-American Association of Ophthalmology (PAAO) Joint Meeting, includes a Veterans Administration study that indicates that Iraq and Afghanistan veterans with vision loss from traumatic brain injury have significantly poorer quality of life than comparable civilian patients, and a Harvard doctor's insights on how to best evaluate and care for low-vision patients who experience vivid visual hallucinations due to Charles Bonnet syndrome.
› Verified 2 days ago